Caris Life Sciences Director Executes Substantial Open-Market Stock Purchase
Jeff L. Vacirca, a member of the board of directors at Caris Life Sciences, Inc. (NASDAQ: CAI), has significantly increased his position in the company through a recent purchase of common stock. The transaction, valued at approximately $501,426, involved the acquisition of 31,050 shares. This move comes at a period where the company's stock is navi…